Skip to the rundown
GetYourBrief
Search

Week brief · June 8 to 14, 2026

Biotech news, week of June 8, 2026

In the week of June 8 to 14, 2026 the Biotech desk recorded 8 news events on 4 days. Pharma led with 3.

The most covered stories of the week

  1. Jun 11 Do No Harm urges Congress to codify safeguards for children 8
  2. Jun 12 leaderlive.co.uk: “Everything to know about the new Wegovy weight loss pill” 3
  3. Jun 11 CStone reports CS2009 data presented at ASCO 2026 2
  4. Jun 11 Study surveys Colorado adults over 60 on edible cannabis use 2
  5. Jun 12 benzinga.com: “UID and AEG ID Combine to Expand Industrial RFID Solutions Across North America” 2
  6. Jun 14 3 Infant Botulism Cases Trigger Nara Organics Voluntary Recall 2
  7. Jun 14 Nadda says West Asia crisis has hit fertiliser and pharma sectors 1

Thursday, June 11, 2026

  1. 01

    Do No Harm urges Congress to codify safeguards for children

    8 outlets · first: themercury.com Fda approval

    Machine summary Key facts from the reports:

    1. Do No Harm is urging Congress to "codify safeguards" to protect children from transgender ideology, according to The Center Square.

    Reported by themercury.com, ttownmedia.com, emporiagazette.com, hendersondispatch.com, mohavedailynews.com, wyomingnews.com, greenevillesun.com and dailypostathenian.com.

  2. 02

    CStone reports CS2009 data presented at ASCO 2026

    2 outlets · first: Pr Newswire Clinical trial Mostly press releases

    Machine summary CStone said clinical datasets for CS2009, a PD-1/VEGF/CTLA-4 trispecific antibody, were presented at ASCO 2026. The company said the data support the antibody's trispecific mechanism and described it as a next-generation immuno-oncology backbone therapy.

    1. CStone said the clinical datasets for CS2009 were presented at ASCO 2026.
    2. CStone said the datasets further validate the trispecific synergistic mechanism of CS2009.
    3. CStone said CS2009 was designed to target PD-1, VEGF and CTLA-4 simultaneously.
    4. CStone said that promising anti-tumor activity had been seen in multiple tumor types that traditionally do not respond to immunotherapy, including immunotherapy-resistant non-small cell lung cancer, pMMR/MSS metastatic colorectal cancer, soft tissue sarcoma, and non-clear cell renal cell carcinoma.

    Reported by Pr Newswire and torontotelegraph.com (Big News Network).

  3. 03

    Study surveys Colorado adults over 60 on edible cannabis use

    2 outlets · first: kunc.org Pharma

    Machine summary Key facts from the reports:

    1. Delaney said some respondents were concerned about impairment from THC, and that researchers learned many older adults do not disclose their cannabis use with their doctors.

    Reported by kunc.org and kunr.org.

Friday, June 12, 2026

  1. 04

    Coverage recordleaderlive.co.uk: “Everything to know about the new Wegovy weight loss pill”

    3 outlets · first: dailymail.com Clinical trial

    Reports ran from 11:15 UTC on Jun 12 to 05:45 UTC on Jun 15.

    The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

    Reported by dailymail.com, leaderlive.co.uk and tivysideadvertiser.co.uk.

    • Wegovy Pill
  2. 05

    Coverage recordbenzinga.com: “UID and AEG ID Combine to Expand Industrial RFID Solutions Across North America”

    2 outlets · first: Benzinga Acquisition Mostly press releases

    The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

    Reported by Benzinga and globenewswire.com.

    • RFID
    • Unified Information Devices (UID)

Sunday, June 14, 2026

  1. 06

    3 Infant Botulism Cases Trigger Nara Organics Voluntary Recall

    2 outlets · first: cbsnews.com Pharma

    Machine summary A cluster of three infant botulism cases, despite zero positive C. botulinum tests in product lots, has forced Nara Organics to recall all whole milk powdered formula.

    1. Nara Organics voluntarily recalls all whole milk powder infant formula after 3 infants hospitalized with botulism.
    2. No product lots tested positive for C. botulinum, but 3 lots linked to illnesses: 709125280E14F2, 709125288E14F2, and 708125174E14F2.
    3. Product sold at Target stores, Target.com, and Nara.com; not distributed outside the US.
    4. FDA and CDC investigation ongoing; recall is voluntary with company cooperation.

    Reported by cbsnews.com and newson6.com.

  2. 07

    Nadda says West Asia crisis has hit fertiliser and pharma sectors

    1 outlet · first: indiagazette.com (Big News Network) Pharma

    Machine summary Speaking to mediapersons in Shimla, Nadda said India had diversified its sourcing and strengthened supply arrangements, and that it has moved towards alternative fertiliser sources and is issuing fresh tenders with countries including Indonesia, Australia, Russia and China.

    1. Nadda said the government has taken adequate measures to ensure farmers and consumers do not face hardship, according to ANI.
    2. Nadda said there are sufficient fertiliser stocks for the ongoing Kharif season and that preparations are underway for the Rabi season, according to ANI.

    Reported by indiagazette.com (Big News Network), milwaukeesun.com (Big News Network), russiaherald.com (Big News Network) and asiabulletin.com (Big News Network).

More events reported

No summary of ours and no outlet headline passed our automated checks for these, which says nothing about the events (how they work); the outlets and their reports are linked.

Saturday, June 13, 2026

  1. · 2 outletseconomictimes.indiatimes.com, timesfreepress.com

Summaries and key facts are machine summaries of the reports linked with them; outlets, times and counts come from those reports. How a rundown is built.

What kind of news was it?

  1. Pharma 3
  2. Clinical trial 2
  3. Fda approval 1
  4. Acquisition 1

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).